Compare MRVI & AMBQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRVI | AMBQ |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | 2025 |
| Metric | MRVI | AMBQ |
|---|---|---|
| Price | $7.13 | $41.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $9.64 | ★ $66.71 |
| AVG Volume (30 Days) | ★ 2.0M | 395.9K |
| Earning Date | 11-04-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 14.29 | ★ 95.97 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $185,743,000.00 | $72,514,000.00 |
| Revenue This Year | $15.38 | $90.04 |
| Revenue Next Year | $4.79 | $37.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.80 | $22.75 |
| 52 Week High | $9.42 | $91.61 |
| Indicator | MRVI | AMBQ |
|---|---|---|
| Relative Strength Index (RSI) | 45.63 | 44.61 |
| Support Level | $6.54 | $33.51 |
| Resistance Level | $7.60 | $54.49 |
| Average True Range (ATR) | 0.51 | 4.12 |
| MACD | -0.06 | 0.66 |
| Stochastic Oscillator | 28.62 | 59.58 |
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Ambiq Micro Inc is a fabless semiconductor company that has developed technology based on a patented Sub-threshold Power Optimized Technology (SPOT) platform that significantly reduces the amount of power consumed by integrated circuits. It is a pioneer and provider of ultra-low power semiconductor solutions designed to address the power consumption challenges of general purpose and AI compute - especially at the edge. The company provides a full-stack solution encompassing tightly integrated hardware and software. Its solutions include a diverse family of systems-on-chip (SoCs) and the software required to enable on-chip AI processing, general compute, sensing, security, storage, wireless connectivity, and developed graphics.